Showing results (11-20 of 24) with videos related to

Sort By:
Pageof 3
British Journal of Clinical Pharmacology|May 1, 1980
The effect of metoclopramide and atropine on the absorption of orally administered mexiletineL M Wing, P J Meffin, J J Grygiel, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|November 1, 1992
Severe vascular adverse effects with thrombocytopenia and renal failure following emetogenic chemotherapy and ondansetronA S Coates, A Childs, K Cox, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 1, 1994
Multiple atypical nevi: a cutaneous marker of germ cell tumorsD Raghavan, J R Zalcberg, J J Grygiel, et al.
British Journal of Urology|May 1, 1992
Phase II clinical trial of recombinant alpha-2 interferon for biopsy-proven metastatic or recurrent renal carcinomaM A Rosenthal, K Cox, D Raghavan, et al.
European Journal of Clinical Pharmacology|January 1, 1982
Effects of once daily indapamide and pindolol on blood pressure, plasma aldosterone concentration and plasma renin activity in a general practice settingJ P Chalmers, L M Wing, J J Grygiel, et al.
The Medical Journal of Australia|March 8, 1980
Comparison of labetalol, hydrallazine, and propranolol in the therapy of moderate hypertensionM J West, L M Wing, J Mulligan, et al.
British Journal of Urology|November 1, 1993
Oral cyclophosphamide for the management of hormone-refractory prostate cancerD Raghavan, K Cox, B S Pearson, et al.
Cancer Research|September 1, 1983
A phase I and pharmacokinetic study of diamminecyclobutane-dicarboxylatoplatinum (NSC 241240)G A Curt, J J Grygiel, B J Corden, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 12, 2001
Overexpression of the cell cycle inhibitor p16INK4A in high-grade prostatic intraepithelial neoplasia predicts early relapse in prostate cancer patientsS M Henshall, D I Quinn, C S Lee, et al.
Cancer Research|February 24, 2001
Altered expression of androgen receptor in the malignant epithelium and adjacent stroma is associated with early relapse in prostate cancerS M Henshall, D I Quinn, C S Lee, et al.
Pageof 3